Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPLORE: Lamivudine and Adefovir Strategies in HBeAg-Positive CHB
NCT01088009Phase 4Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Mar 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by Nanfang Hospital, Southern Medical University. Started Mar 2010; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01088009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088009.